George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.50
Bid: 140.00
Ask: 145.00
Change: 2.50 (1.79%)
Spread: 5.00 (3.571%)
Open: 142.50
High: 142.50
Low: 142.50
Prev. Close: 140.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update regarding the PACCAR Matter

1 Aug 2023 11:33

RNS Number : 9349H
Manolete Partners PLC
01 August 2023
 

1 August 2023

 

Manolete Partners Plc

("Manolete" or the "Company")

 

Update regarding: PACCAR Inc & Ors v Competition Appeal Tribunal & Ors, [2023] UKSC 28 ("the PACCAR Matter")

 

Manolete Partners plc (AIM:MANO), the leading quoted UK insolvency litigation financing company, is pleased to provide the following commentary regarding the above matter.

 

The Company has always stated that the key difference in Manolete's business model is that it overwhelmingly purchases, rather than funds, its case investments. This is because the Insolvency Act 1986 uniquely allows a Liquidator and Administrator ("Office Holder") to sell an insolvent company's legal claims to third parties, for the benefit of creditors. These powers were further extended by the Small Business Enterprise and Employment Act 2015, which allow the Liquidator and Administrator to sell the claims that arise in their capacity as an Office Holder of the insolvent company to a third party.

 

The PACCAR Matter is a Supreme Court ruling that relates to a number of funded claims in relation to Truck Cartel price fixing being heard in the UK's Competition Appeal Tribunal. Manolete also has a number of claims in relation to the same matter. All of Manolete's claims have been purchased by Manolete. None are funded. The Supreme Court ruling therefore has no relevance to Manolete's claims in this matter.

 

Looking at Manolete's total current portfolio of UK insolvency claims: as at the end of June 2023, the Company had 390 live cases with a combined Net Book Value of £31.5m. 94% by volume and 95% by Net Book Value related to Purchased cases; 6% by volume and 5% by Net Book Value related to Funded cases.

 

Of the 23 (out of a total of 390 live cases) that are Funded cases, Manolete is working with specialist counsel to determine any amendments that may be required to the terms of Manolete's standard funding agreement.

 

Over 95% of Manolete's successfully completed cases are completed by way of a consensual settlement agreement with the defendant (often an individual previous company director). Very few end at a trial. The Board considers that the prospect of any party seeking to re-open a previously completed Funded Case as highly remote.

 

If any further material matters arise from our work with specialist counsel in this area, we will provide a further update.

 

For further information, please contact:

Manolete Partners Plc

Steven Cooklin (Chief Executive Officer)

 

via Instinctif Partners

Peel Hunt (NOMAD and Broker)

Paul Shackleton

 

+44 (0)20 7418 8900

 

 

Instinctif Partners (Financial PR)

Tim Linacre

Victoria Hayns

 

+44 7949 939237

manolete@instinctif.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAORROAUWRAR
Date   Source Headline
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 202111:03 amRNSDirector/PDMR Dealings
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.